Professional Publications

Cernan, M.; Szotkowski, T.; Hisemova, M.; Cetkovsky, P.; et al.

Blastic plasmacytoid dendritic cell neoplasm: first retrospective study in the Czech Republic

[year of publication 2020, impact factor 2.575 ]

Cario, H.; McMullin, M.F.; Bento, C.; Pospisilova, D.; Percy, M.J.; Hussein, K.; Schwarz, J.; Astrom, M.; Hermouet, S.

Erythrocytosis in children and adolescents-classification, characterization, and consensus recommendations for the diagnostic approach

[year of publication 2013, impact factor 2.562 ]

Gregorová, S.; Mňuková-Fajdelová, M.; Trachtulec, Z.; Čapková, J.; Loudová, M.; Höglund, M.; Hamvas, R.; Lehrach, H.; Vincek, V.; Klein, J.; Forejt, J.

Sub-milliMorgan map of the proximal part of mouse chromosome 17 including the hybrid sterility 1 gene

[year of publication 2006, impact factor 2.561]

Babicka, L.; Ransdorfova, S.; Brezinova, J.; Zemanova, Z.; Sindelarova, L.; Siskova, M.; Maaloufova, J.; Cermak, J.; Michalova, K.

Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH

[year of publication 2007, impact factor 2.561]

Rulcová, J.; Zmeková, V.; Zemanová, Z.; Klamová, H.; Moravcová, J.

The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR

[year of publication 2007, impact factor 2.561]

Merkerova, M.; Bruchova, H.; Brdicka, R.

Expression analysis of PCNA gene in chronic myelogenous leukemia : combined application of siRNA silencing and expression arrays

[year of publication 2007, impact factor 2.561]

Michiels, J.J.; De Raeve, H.; Hebeda, K.; Lam, K.H.; Berneman, Z.; Schroyens, W.; Schwarz, J.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders

[year of publication 2007, impact factor 2.561]

Smetana, K.; Jirásková, I.; Turek, P.; Chan, P.K.; Busch, H.

A contribution to the incidence of nucleoli in normal human blood lymphocytes

[year of publication 2006, impact factor 2.560]

Indrová, M.; Bieblová, J.; Jandlová, T.; Vonka, V.; Pajtasz-Piasecka E.; Reinis, M.

Chemotherapy, IL–12 gene therapy and combined adjuvant therapy of HPV16–associated MHC class I–proficient and deficient tumours

[year of publication 2007, impact factor 2.556]

Ullmannova, V.; Popescu, N.C.

Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors

[year of publication 2007, impact factor 2.556]

Vasikova, A.; Belickova, M.; Budinska, E.; Cermak, J.

A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome

[year of publication 2010, impact factor 2.555]

Pumannova, M.; Roubalova, K.; Vitek, A.; Sajdova, J.

Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation

[year of publication 2007, impact factor 2.553]

Saláková, M.; Němeček, V.; Tachezy, R.

TTV and HPV co-infection in cervical smears of patients with cervical lesions

[year of publication 2009, impact factor 2.550]

Grebeňová, D.; Kuželová, K.; Fuchs, O.; Halada, P.; Havlíček, V.; Marinov, I.; Hrkal, Z.

Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis

[year of publication 2006, impact factor 2.549]

Marková, J.; Michková, P.; Burčková, K.; Březinová, J.; Michalová, K.; Dohnalová, A.; Soukupová Maaloufová, J.; Soukup, P.; Vítek, A.; Cetkovský, P.; Schwarz, J.

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia

[year of publication 2011, impact factor 2.548 ]

Zurkova, K.; Hainz, P.; Krystofova, J.; Kutinova, L.; Sanda, M.; Nemeckova, S.

Attenuation of vaccinia virus by the expression of human Flt3 ligand

[year of publication 2010, impact factor 2.546]

Jonasova, A.; Bokorova, R.; Polak, J.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Sponerova, D.; Cermak, J.; Mikulenkova, D.; Cervinek, L.; Brezinova, J.; Michalova, K.; Fuchs, O.

High level of full length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide

[year of publication 2014, impact factor 2.544 ]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[year of publication 2014, impact factor 2.544 ]

Vyhlídalová, I.; Uherková, L.; Pleschnerová, M.; Špička, I.; Březinová, J.; Michalová, K.; Čermáková, K.; Polanská, V.; Jedelský, P.L.; Hamšíková, E.; Kuželová, K.; Stöckbauer, P.

Characterization of a new human plasma cell leukemia cell line UHKT-944

[year of publication 2015, impact factor 2.544 ]

Langabeer, S.E.; Andrikovics, H.; Asp, J.; Bellosillo, B.; Carillo, S.; Haslam, K.; Kjaer, L.; Lippert, E.; Mansier, O.; Oppliger Leibundgut, E.; Percy, M.J.; Porret, N.; Palmqvist, L.; Schwarz, J.; McMullin, M.F.; Schnittger, S.; Pallisgaard, N.; Hermouet, S.

Molecular diagnostics of myeloproliferative neoplasms (MPN)

[year of publication 2015, impact factor 2.544 ]